Working… Menu

HEALEY ALS Platform Trial - Regimen A Zilucoplan

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04436497
Recruitment Status : Enrolling by invitation
First Posted : June 18, 2020
Last Update Posted : October 30, 2020
Ra Pharmaceuticals
Information provided by (Responsible Party):
Merit E. Cudkowicz, MD, Massachusetts General Hospital

No Study Results Posted on for this Study
Recruitment Status : Enrolling by invitation
Estimated Primary Completion Date : October 2021
Estimated Study Completion Date : December 2022